PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIA...

por Al-Ali, Haifa Kathrin, Mesa, Ruben, Hamer-Maansson, J.E., Braunstein, Evan, Harrison, Claire
Publicado 2023

P1045: DISEASE PROGRESSION AND LEUKEMIC TRANSFORMATION IN PATIENTS WITH LOWER-RISK MYELOFIBROSIS: AN ANALYSIS FROM MOST

por Komrokji, Rami S., Grunwald, Michael, Braunstein, Evan, Hamer-Maansson, J.E., Kalafut, Tricia, Mascarenhas, John
Publicado 2023

P1046: TREATMENT COMPARISON OF HYDROXYUREA VS RUXOLITINIB IN ESSENTIAL THROMBOCYTHEMIA (ET): A MATCHED COHORT ANALYSIS

por Grunwald, Michael, Ritchie, Ellen, Rumi, Elisa, Assad, Albert, Hamer-Maansson, J.E., Yu, Jingbo, Braunstein, Evan, Passamonti, Francesco
Publicado 2023